Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 19.85 Billion | USD 32.96 Billion | 5.20% | 2024 |
FrequentlyAsked Questions
Pediatric clinical trials are drug discovery and development-oriented procedures that aim to develop child-specific medicines and treatment plans.
The global pediatric clinical trials market is expected to be driven by the rising cases of pediatric disorders and medical conditions reported worldwide.
According to study, the global pediatric clinical trials market size was worth around USD 19.85 billion in 2024 and is predicted to grow to around USD 32.96 billion by 2034.
The CAGR value of the pediatric clinical trials market is expected to be around 5.20% during 2025-2034.
The global pediatric clinical trials market will be led by North America during the forecast period.
The global pediatric clinical trials market is led by players like PRA Health Sciences, IQVIA Holdings, Inc., Parexel International Corporation, MD Anderson Cancer Center, Charles River Laboratories International Inc., Medigrowth, PPD (Pharmaceutical Product Development), Texas Children's Hospital, Syneos Health Inc., Syrona Health, Covance Inc., Novo Nordisk, ICON plc, KCR, and Medpace Holdings, Inc.
The report explores crucial aspects of the pediatric clinical trials market, including a detailed discussion of existing growth factors and restraints, while browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed